New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia

Simple item page
dc.contributor.authorCristina Alonso‐Vega
dc.contributor.authorJulio A. Urbina
dc.contributor.authorSergi Sanz
dc.contributor.authorMaría‐Jesús Pinazo
dc.contributor.authorJimy Pinto
dc.contributor.authorVirginia Gonzalez
dc.contributor.authorGimena Rojas
dc.contributor.authorLourdes Ortiz
dc.contributor.authorWilson García
dc.contributor.authorDaniel Lozano
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:58:03Z
dc.date.available2026-03-22T13:58:03Z
dc.date.issued2021
dc.descriptionCitaciones: 36
dc.description.abstractNCT03981523.
dc.identifier.doi10.1136/bmjopen-2021-052897
dc.identifier.urihttps://doi.org/10.1136/bmjopen-2021-052897
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43768
dc.language.isoen
dc.publisherBMJ
dc.relation.ispartofBMJ Open
dc.sourceBarcelona Institute for Global Health
dc.subjectMedicine
dc.subjectClinical trial
dc.subjectDisease
dc.subjectChemotherapy
dc.subjectChagas disease
dc.subjectOpen label
dc.subjectEpidemiology
dc.subjectGerontology
dc.subjectInternal medicine
dc.subjectPhysical therapy
dc.titleNew chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia
dc.typearticle

Files

Collections

Artículo Científico Publicado